Is Adalta Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Adalta Ltd (1AD.AX) is currently classified as HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Adalta Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Adalta Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Adalta Ltd?

Muslim investors may consider investing in Adalta Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Adalta Ltd classified as HALAL?

Musaffa determines the Shariah status of Adalta Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Adalta Ltd updated?

The Shariah compliance status of Adalta Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Adalta Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Adalta Ltd?

You can check the latest Shariah compliance status of Adalta Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

1AD.AX Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: July 31, 2025

Report Source: 2025 2nd Quarter Report

Analyst's Ratings for Adalta Ltd (1AD.AX)

Based on 7 analysts giving stock ratings to Adalta Ltd in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Adalta Ltd. Stock Analysis 1AD.AX

Australia Health Care Nano Cap Report: Q2, 2025

AdAlta Ltd. operates as a biotechnology company, discovers, develops, and commercializes protein based therapeutics. The firm uses its i-body platform to discover and develop protein therapeutics addressing drug targets that are challenging for other technologies. The firm's first-in-class lead asset, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases, for which current therapies are sub-optimal. AD-214 is an Fc-Fusion protein that contains two AD-114 i-body molecules at the front end, that bind with high affinity to the human target, CXCR4. The company is also engaged in developing i-body enabled Chimeric antigen receptor T cell (CAR-T) cells. The company co-develops i-bodies as diagnostic imaging agents (i-PET imaging) against Granzyme B, a biomarker of response to immuno-oncology drugs.

Key Statistics of Adalta Ltd (1AD.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.01AUD0.01

Today's Open

AUD0.01

Volume

11.44K

P/E Ratio (TTM)

52 Week Range

AUD0.00AUD0.01

Market Cap

11.47M

Avg. Volume

4.20M

Dividend Yield

Financial Metrics & Statements of Adalta Ltd (1AD.AX)

FAQ's for Adalta Ltd (1AD.AX)

According to Musaffa’s Shariah screening methodology, Adalta Ltd (1AD.AX) is currently classified as HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.